Concepts (140)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Smell | 5 | 2022 | 131 | 2.720 |
Why?
|
| Olfactory Perception | 5 | 2018 | 20 | 2.690 |
Why?
|
| Odorants | 5 | 2021 | 52 | 1.650 |
Why?
|
| Anxiety | 4 | 2021 | 422 | 1.600 |
Why?
|
| Transcranial Direct Current Stimulation | 2 | 2022 | 111 | 1.300 |
Why?
|
| Cues | 3 | 2015 | 654 | 1.080 |
Why?
|
| Stress Disorders, Post-Traumatic | 6 | 2017 | 1506 | 0.860 |
Why?
|
| Trigeminal Nerve | 2 | 2022 | 22 | 0.800 |
Why?
|
| Magnetic Resonance Imaging | 7 | 2015 | 2223 | 0.800 |
Why?
|
| Tobacco Use Disorder | 2 | 2015 | 432 | 0.710 |
Why?
|
| Obsessive-Compulsive Disorder | 2 | 2019 | 88 | 0.700 |
Why?
|
| Perceptual Disorders | 1 | 2019 | 23 | 0.660 |
Why?
|
| Combat Disorders | 2 | 2017 | 102 | 0.620 |
Why?
|
| Olfaction Disorders | 1 | 2019 | 100 | 0.580 |
Why?
|
| Smoking | 2 | 2015 | 1452 | 0.560 |
Why?
|
| Brain | 4 | 2017 | 2176 | 0.540 |
Why?
|
| Veterans | 4 | 2017 | 904 | 0.540 |
Why?
|
| Olfactory Cortex | 1 | 2015 | 3 | 0.520 |
Why?
|
| Sensory Thresholds | 3 | 2021 | 50 | 0.500 |
Why?
|
| Glutamic Acid | 3 | 2009 | 332 | 0.500 |
Why?
|
| Craving | 2 | 2021 | 200 | 0.490 |
Why?
|
| Depressive Disorder | 1 | 2018 | 621 | 0.480 |
Why?
|
| Galvanic Skin Response | 1 | 2014 | 67 | 0.480 |
Why?
|
| Visual Cortex | 1 | 2014 | 67 | 0.450 |
Why?
|
| Adult | 14 | 2022 | 21403 | 0.450 |
Why?
|
| Visual Perception | 1 | 2014 | 124 | 0.440 |
Why?
|
| Prefrontal Cortex | 3 | 2015 | 640 | 0.440 |
Why?
|
| Heart Rate | 1 | 2014 | 568 | 0.410 |
Why?
|
| Behavior, Addictive | 1 | 2015 | 317 | 0.400 |
Why?
|
| Anxiety Disorders | 4 | 2009 | 426 | 0.400 |
Why?
|
| Magnetic Resonance Spectroscopy | 3 | 2009 | 346 | 0.380 |
Why?
|
| Brain Mapping | 4 | 2017 | 532 | 0.380 |
Why?
|
| Motivation | 1 | 2014 | 561 | 0.360 |
Why?
|
| Humans | 23 | 2022 | 68618 | 0.320 |
Why?
|
| Risk-Taking | 1 | 2009 | 210 | 0.310 |
Why?
|
| Male | 16 | 2019 | 37321 | 0.310 |
Why?
|
| Panic Disorder | 3 | 2009 | 121 | 0.300 |
Why?
|
| Female | 15 | 2022 | 38074 | 0.300 |
Why?
|
| Immobility Response, Tonic | 1 | 2006 | 3 | 0.280 |
Why?
|
| Freezing Reaction, Cataleptic | 1 | 2006 | 10 | 0.280 |
Why?
|
| Caudate Nucleus | 1 | 2006 | 56 | 0.270 |
Why?
|
| Fear | 3 | 2019 | 239 | 0.270 |
Why?
|
| Young Adult | 6 | 2019 | 5717 | 0.270 |
Why?
|
| Adolescent | 5 | 2021 | 8912 | 0.250 |
Why?
|
| Substance-Related Disorders | 1 | 2014 | 1242 | 0.250 |
Why?
|
| Prenatal Exposure Delayed Effects | 1 | 2006 | 154 | 0.250 |
Why?
|
| Middle Aged | 10 | 2019 | 21147 | 0.240 |
Why?
|
| Sleep Wake Disorders | 2 | 2016 | 94 | 0.210 |
Why?
|
| Child | 4 | 2021 | 6405 | 0.200 |
Why?
|
| Nicotine | 2 | 2015 | 350 | 0.200 |
Why?
|
| Electric Stimulation | 1 | 2022 | 218 | 0.190 |
Why?
|
| Rhinitis | 2 | 2016 | 383 | 0.190 |
Why?
|
| Sinusitis | 2 | 2016 | 432 | 0.180 |
Why?
|
| Ethanol | 1 | 2006 | 893 | 0.170 |
Why?
|
| Pain Threshold | 1 | 2019 | 55 | 0.160 |
Why?
|
| Depression | 2 | 2016 | 943 | 0.160 |
Why?
|
| Child Behavior Disorders | 1 | 2019 | 69 | 0.160 |
Why?
|
| Diagnostic Self Evaluation | 1 | 2018 | 18 | 0.160 |
Why?
|
| Double-Blind Method | 1 | 2022 | 1738 | 0.150 |
Why?
|
| Olfactory Pathways | 1 | 2017 | 9 | 0.150 |
Why?
|
| Aged | 5 | 2019 | 14862 | 0.140 |
Why?
|
| Magnetic Resonance Angiography | 1 | 2017 | 181 | 0.140 |
Why?
|
| Analgesics, Opioid | 1 | 2021 | 498 | 0.140 |
Why?
|
| Otologic Surgical Procedures | 1 | 2016 | 23 | 0.130 |
Why?
|
| Drug Hypersensitivity | 1 | 2016 | 35 | 0.130 |
Why?
|
| Rubber | 1 | 2015 | 13 | 0.130 |
Why?
|
| Physical Stimulation | 1 | 2015 | 67 | 0.130 |
Why?
|
| Memory, Episodic | 1 | 2015 | 10 | 0.130 |
Why?
|
| Gray Matter | 1 | 2015 | 57 | 0.120 |
Why?
|
| Organ Size | 1 | 2015 | 242 | 0.120 |
Why?
|
| Case-Control Studies | 2 | 2016 | 1553 | 0.120 |
Why?
|
| Psychiatric Status Rating Scales | 2 | 2015 | 782 | 0.120 |
Why?
|
| Sleep | 1 | 2016 | 263 | 0.120 |
Why?
|
| Disease Management | 1 | 2016 | 248 | 0.120 |
Why?
|
| Image Enhancement | 1 | 2014 | 143 | 0.110 |
Why?
|
| Oxygen Consumption | 1 | 2014 | 258 | 0.110 |
Why?
|
| Attention | 1 | 2015 | 225 | 0.110 |
Why?
|
| Asthma | 1 | 2016 | 345 | 0.100 |
Why?
|
| Mental Disorders | 1 | 2016 | 659 | 0.090 |
Why?
|
| Sleep Paralysis | 2 | 2009 | 4 | 0.090 |
Why?
|
| Tritium | 1 | 2009 | 101 | 0.090 |
Why?
|
| Maze Learning | 1 | 2009 | 138 | 0.080 |
Why?
|
| Sleep Deprivation | 1 | 2009 | 81 | 0.080 |
Why?
|
| Lithium Carbonate | 1 | 2009 | 31 | 0.080 |
Why?
|
| Antimanic Agents | 1 | 2009 | 21 | 0.080 |
Why?
|
| Anti-Bacterial Agents | 1 | 2016 | 1026 | 0.080 |
Why?
|
| Statistics as Topic | 1 | 2009 | 219 | 0.080 |
Why?
|
| Cataplexy | 1 | 2009 | 25 | 0.080 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2009 | 381 | 0.080 |
Why?
|
| Comorbidity | 4 | 2016 | 1426 | 0.080 |
Why?
|
| Narcolepsy | 1 | 2009 | 45 | 0.080 |
Why?
|
| Quality of Life | 1 | 2016 | 1515 | 0.070 |
Why?
|
| Behavior, Animal | 1 | 2009 | 470 | 0.070 |
Why?
|
| Smoking Cessation | 1 | 2015 | 1034 | 0.070 |
Why?
|
| Surveys and Questionnaires | 3 | 2016 | 2800 | 0.070 |
Why?
|
| Bipolar Disorder | 1 | 2009 | 307 | 0.070 |
Why?
|
| Arousal | 1 | 2005 | 168 | 0.060 |
Why?
|
| Excitatory Amino Acid Antagonists | 1 | 2005 | 128 | 0.060 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2009 | 2083 | 0.060 |
Why?
|
| Gyrus Cinguli | 1 | 2005 | 113 | 0.060 |
Why?
|
| Anticonvulsants | 1 | 2005 | 223 | 0.060 |
Why?
|
| Social Behavior | 1 | 2005 | 164 | 0.060 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2006 | 689 | 0.050 |
Why?
|
| Retrospective Studies | 1 | 2015 | 7277 | 0.050 |
Why?
|
| Aspartic Acid | 1 | 2003 | 65 | 0.050 |
Why?
|
| Clonidine | 1 | 2021 | 66 | 0.050 |
Why?
|
| Rats | 1 | 2009 | 5300 | 0.050 |
Why?
|
| Clinical Trials as Topic | 1 | 2005 | 848 | 0.050 |
Why?
|
| Hypothalamo-Hypophyseal System | 1 | 2021 | 150 | 0.050 |
Why?
|
| Pituitary-Adrenal System | 1 | 2021 | 138 | 0.050 |
Why?
|
| Chronic Disease | 2 | 2016 | 1330 | 0.050 |
Why?
|
| Pregnancy | 1 | 2006 | 2334 | 0.050 |
Why?
|
| Animals | 2 | 2009 | 20881 | 0.050 |
Why?
|
| United States | 3 | 2016 | 7367 | 0.040 |
Why?
|
| Recurrence | 1 | 2021 | 948 | 0.040 |
Why?
|
| Prospective Studies | 2 | 2016 | 3705 | 0.040 |
Why?
|
| Disease Models, Animal | 1 | 2005 | 2550 | 0.040 |
Why?
|
| Pandemics | 1 | 2021 | 352 | 0.040 |
Why?
|
| Alberta | 1 | 2016 | 15 | 0.030 |
Why?
|
| Follow-Up Studies | 2 | 2016 | 3259 | 0.030 |
Why?
|
| Canada | 1 | 2016 | 267 | 0.030 |
Why?
|
| Endoscopy | 1 | 2016 | 464 | 0.030 |
Why?
|
| Incidence | 1 | 2016 | 1603 | 0.020 |
Why?
|
| Prognosis | 1 | 2016 | 2093 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2016 | 2358 | 0.020 |
Why?
|
| Hypnotics and Sedatives | 1 | 2009 | 96 | 0.020 |
Why?
|
| Anti-Anxiety Agents | 1 | 2009 | 107 | 0.020 |
Why?
|
| Diagnostic and Statistical Manual of Mental Disorders | 1 | 2009 | 257 | 0.020 |
Why?
|
| Sleep Initiation and Maintenance Disorders | 1 | 2009 | 91 | 0.020 |
Why?
|
| Time Factors | 1 | 2016 | 4655 | 0.020 |
Why?
|
| Behavior Therapy | 1 | 2009 | 297 | 0.020 |
Why?
|
| Models, Theoretical | 1 | 2009 | 384 | 0.020 |
Why?
|
| Diagnosis, Differential | 1 | 2009 | 1140 | 0.020 |
Why?
|
| Occipital Lobe | 1 | 2005 | 18 | 0.020 |
Why?
|
| Protons | 1 | 2005 | 57 | 0.020 |
Why?
|
| Severity of Illness Index | 1 | 2009 | 1851 | 0.010 |
Why?
|
| Choline | 1 | 2003 | 14 | 0.010 |
Why?
|
| Creatine | 1 | 2003 | 30 | 0.010 |
Why?
|
| Image Interpretation, Computer-Assisted | 1 | 2003 | 237 | 0.010 |
Why?
|
| Biomarkers | 1 | 2003 | 1593 | 0.010 |
Why?
|